OverviewChartNewsTraderScreen

Soc. Generale Call 110 AZN 20.12..../  DE000SU796X0  /

EUWAX
11/13/2024  8:15:11 AM Chg.0.000 Bid10:00:40 PM Ask10:00:40 PM Underlying Strike price Expiration date Option type
0.071EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 Astrazeneca PLC ORD ... 110.00 GBP 12/20/2024 Call
TeleTrader 11/12 AstraZeneca's revenue in Q3 rises 21% to $13.5B
GlobeNewswire 8/12 Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire 8/8 Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire 8/6 Cellectis Provides Financial Results for the Second Quarter 2024
TeleTrader 7/25 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 7/15 AstraZeneca Closes Acquisition of Amolyt Pharma
GlobeNewswire 6/26 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 6/18 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 6/18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 6/13 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 5/28 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 5/21 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 5/20 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 5/8 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 5/6 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 5/6 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 4/29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 3/28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 3/19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 3/18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 3/14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 3/14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 2/28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates